Evaluation and determinants of underprescription of erythropoiesis stimulating agents in pre-dialysis patients with anaemia.: Adequacy of anaemia correction in ESRD patients

Thilly, Nathalie
Stengel, Bénédicte
Boini, Stephanie
Villar, Emmanuel
Couchoud, Cecile
Frimat, Luc

Open link

Publication date

January 2008

DOI

10.1159/000112914

Publisher

HAL CCSD

Abstract

International audienceBACKGROUND: Inadequate anaemia correction (haemoglobin (Hb) <11 g/dl without receiving an erythropoiesis-stimulating agent (ESA) is common in pre-dialysis patients, but little is known about its determinants. We used data from the French end-stage renal disease (ESRD) registry to investigate these determinants and the patients' anaemia status 1 year after starting dialysis. METHODS: Pre-dialysis anaemia care was studied in 6,271 incident ESRD patients from 13 regions, who were first treated between 2003 and 2005. Data included pre-dialysis Hb measure and ESA use, patient's condition and modalities of dialysis initiation. Anaemia status at 1 year was studied in 925 patients from four regions who started dialysis in 2003...